午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Benvitimod Impurity 12
Benvitimod Impurity 12
  • Benvitimod Impurity 12
  • Benvitimod Impurity 12
  • Benvitimod Impurity 12
  • Benvitimod Impurity 12
  • Benvitimod Impurity 12

Benvitimod Impurity 12 NEW

Price Get Latest Price
Package 10mg 50mg 100mg
Min. Order: 10mg
Supply Ability: 1000
Update Time: 2025-07-31

Product Details

Product Name: Benvitimod Impurity 12 CAS No.: 141509-20-8
Min. Order: 10mg Purity: 99%+ HPLC
Supply Ability: 1000 Release date: 2025/07/31
Molecular formula: C19H22O2

Benvitimod Impurity 12;344396-18-5

Article illustration

WhatsAPP: +86 17386083646
E-mail: anna@molcoo.com

  • Product Number: B051012
    English Name: Benvitimod Impurity 12
    English Alias: (E)-2-isopropyl-1,3-dimethoxy-5-styrylbenzene
    CAS Number: 141509-20-8
    Molecular Formula: C19H22O2
    Molecular Weight: 282.38

  • Product Advantages: Benvitimod Impurity 12 has extremely high purity and good chemical stability. Its structure is clear and properties are uniform, remaining stable under different experimental environments and storage conditions. It can be used as an accurate and reliable reference substance. In the process of pharmaceutical impurity analysis, it can effectively improve the accuracy and repeatability of detection results, providing strong support for in-depth research on the quality of Benvitimod drugs and strict quality control.
    Application Fields: It is mainly applied in the quality control and research and development of Benvitimod-related drugs. As an impurity reference standard, it is used to establish and validate the detection methods of Benvitimod impurities, ensuring that the detection methods have high sensitivity and strong specificity. During the drug production process, it monitors the content of this impurity in real-time, assists in optimizing the production process, and prevents excessive impurities from affecting drug quality. In the study of drug stability, it analyzes its change rules during storage, providing key basis for determining the shelf life and suitable storage conditions of drugs.
    Background Description: As an important drug for the treatment of skin diseases such as psoriasis, the quality of Benvitimod is directly related to clinical treatment effects and patients' medication safety. In the whole process of drug research and development, production and quality control, impurity research is an indispensable key part. The presence of impurities may interfere with the active ingredients of drugs, affect drug stability, and even bring potential toxic and side effects. As a related impurity of Benvitimod, in-depth research on Benvitimod Impurity 12 helps to comprehensively and accurately evaluate the quality of Benvitimod drugs, thereby ensuring the safety and effectiveness of clinical medication.
    Research Status: Currently, research on Benvitimod Impurity 12 is continuously deepening and expanding. In terms of detection technology, researchers are constantly exploring more advanced and efficient analytical methods, such as Ultra-Performance Liquid Chromatography - Mass Spectrometry (UPLC - MS) technology and high-resolution mass spectrometry technology, to achieve precise determination of trace impurities. In the study of impurity generation mechanisms, the root causes and influencing factors of its formation are deeply explored by simulating drug synthesis routes and storage environments, providing a solid theoretical basis for controlling impurities from the source. At the same time, research on the interaction between this impurity and Benvitimod and its impact on drug efficacy and safety is also gradually advancing, aiming to further improve the comprehensive cognitive system of Benvitimod drug quality.

NOTE!

We can also customize related analogues and modified peptides including HPLC, MS, 1H-NMR, MS, HPLC, IR, UV, COA, MSDS.
This product is intended for laboratory use only!

WhatsAPP: +86 17386083646
E-mail: anna@molcoo.com


NEW IN STOCK!

The Molcoo Laboratory added drug impurity reference standards, including Baricitinib, Piperazine, Benzylpenicillin, Tranilast and multiple N-Nitroso drug impurities! Now available for immediate delivery! 







Company Profile Introduction

1. Drug standards and drug impurity reference substances: provide more than 20,000 kinds of spot impurity reference substances, with sufficient supply and same-day delivery. We have a professional R&D team and comprehensive quality control testing to ensure product quality and reliability. 2. Customized synthesis of impurities and new molecules: Quickly respond to the customized needs of CDE impurities, stably supply impurities that have established quality standards, and provide customized synthesis services for new compounds in the research and development of innovative drugs. 3. Preparation and separation of unknown impurities: With a professional impurity preparation and separation technical team and SFC preparation and separation instruments, we can solve the problems of impurity preparation in complex projects. 4. Process development of new drug intermediates: provide the supply of new drugs and new molecular impurities, process optimization services, as well as the screening and impurity analysis of commercialization routes. 5. Peptide synthesis: Provide customized peptide synthesis services, and cover all kinds of degradation impurities and process impurities generated in the research and development of peptide drugs. At the same time, it provides comprehensive structural confirmation data and customized testing services.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$0.00/1KG
VIP2Y
Shandong Hanjiang Chemical Co., Ltd
2024-05-10
$40.00/1mg
VIP3Y
Zibo Hangyu Biotechnology Development Co., Ltd
2024-07-09
$0.00/5mg
VIP1Y
Guangzhou Tosun Pharmaceutical Ltd
2025-01-21
INQUIRY